ACE and COVID-19: This is because SARS-CoV-2 infection causes angiotensin-converting enzyme (ACE) and its homolog angiotensin-converting enzyme 2 (ACE/ACE2) balance disruption and renin-angiotensin-aldosterone system (RAAS) activation, which ultimately leads to COVID-19 progression.